91���Ƴ���Ƶ

The medical school will welcome Kenneth Dorshkind, PhD, in September as the featured speaker for Seminars in Investigative Medicine.  

Dr. Dorshkind’s presentation, “Out with the Old and in with the New: A Revised Model of Aging Effects on B Lymphopoiesis,” is scheduled for noon to 1 p.m. on Wednesday, September 30, 2026, in TBL 1 at the W.E. Upjohn M.D. Campus in downtown Kalamazoo. A pizza lunch from Jet’s will be provided for attendees.  

If you plan to attend, please register . Individuals who RSVP will be admitted before those without a reservation.   

Dr. Dorshkind is a Distinguished Research Professor in the Department of Pathology and Laboratory Medicine in the David Geffen School of Medicine at UCLA. He earned his PhD in biological structure from the University of Washington in 1980 and completed a postdoctoral fellowship in hematopoiesis in 1983 at the Ontario Cancer Institute. 

Dr. Dorshkind’s research focuses on lymphocyte development from embryogenesis through senescence. One particular area of interest has been on how the genetic and molecular processes that regulate fetal and adult B and T cell development differ. This work resulted in the identification of a precursor for a specialized type of B lymphocyte, referred to as a B-1 cell, which plays a key role in protection against certain bacterial infections. Another focus of Dr. Dorshkind’s lab is on how aging affects hematopoiesis and B cell development. 

Seminars in Investigative Medicine is a research seminar series at 91���Ƴ���Ƶ aimed at bringing together the community of investigators both within – and outside — the medical school.